SSKN Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 30, 2026
Report Source: 2025 Annual Report
Strata Skin Sciences Inc. Stock Analysis SSKN
STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 114 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Read More Strata Skin Sciences Inc (SSKN) Chart
Key Statistics of Strata Skin Sciences Inc (SSKN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.28Volume
14.02KP/E Ratio (TTM)
-52 Week Range
Market Cap
887.65KAvg. Volume
11.99KDividend Yield
-Financial Metrics & Statements of Strata Skin Sciences Inc (SSKN)
FAQ's for Strata Skin Sciences Inc (SSKN)
- According to Musaffa’s Shariah screening methodology, Strata Skin Sciences Inc (SSKN) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.